Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David M. Aboulafia, MD
Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center
Principal Investigator - Joseph A. Sparano, MD
Albert Einstein College of Medicine
Study Chair - Lisa A. Kachnic, MD
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Ucla Clinical Aids Research and Education (care) Center
Los Angeles, California, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Albert Einstein Cancer Center at Albert Einstein College of Medicine
The Bronx, New York, United States
- Joan Karnell Cancer Center at Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
- Benaroya Research Institute at Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2006
- Primary completion
- 30 Apr 2014
- Completion
- 31 May 2016
- Last update posted
- 30 May 2025
- Registered enrollment
- 45
- Registry id
- NCT00324415
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.